Seth Rudnick, Director at G1 Therapeutics, Inc. (GTHX), sold 11,980 shares at $49.99 ($596K) on 2018-10-04, disclosed to the SEC on 2018-10-05.
Open-market sale of $596k GTHX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.65 | 8,020 | $398K | 66.8% |
| 2 | $49.99 | 1,980 | $99K | 16.6% |
| 3 | $49.99 | 1,980 | $99K | 16.6% |
| Total | $49.76 avg | 11,980 | $596K | 100% |
| Filing → |
| GTHX | SELL | 2020-12-23 | $1.3M | — | Filing → |
| GTHX | SELL | 2020-12-10 | $777K | — | Filing → |
| GTHX | SELL | 2020-12-03 | $10K | — | Filing → |